MB "IVB Pharma Consulting" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statement report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
Working capital requirement |
Debt-to-equity ratio |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2022 |
---|
247,936 |
122,741 |
84,649 |
80,275 |
39,740 |
85.63 |
32.38 |
145,620 |
41,662 |
17,171 |
170,111 |
2023 |
---|
223,245 |
212,614 |
100,459 |
95,927 |
91,359 |
75.62 |
42.97 |
183,659 |
16,590 |
0 |
200,249 |
2024 |
---|
256,854 |
256,854 |
99,759 |
95,478 |
95,478 |
80.27 |
37.17 |
241,298 |
12,122 |
0 |
253,420 |
Register and
explore Okredo dataRegister and
explore Okredo data2024
Turnover (€)
256,854 €15 % *
Sales per employee (€)
256,854 €21 % *
Profit before tax (€)
99,759 €-1 % *
Net Profit (€)
95,478 €0 % *
Profit per employee (€)
95,478 €5 % *
Total profitability (%)
80.27 %6.15 % *
Net profitability (%)
37.17 %-13.50 % *
Equity (€)
241,298 €31 % *
Amounts Payable And Liabilities (€)
12,122 €-27 % *
Non-current Assets (€)
0 €- *
CurrentAssets (€)
253,420 €27 % *